Module XVIII -  New FDA Actions II

Thursday, May 27, 1999 - Question 3

Which of the following statements regarding capecitabine (Xeloda) is correct?

A) Capecitabine is currently available as an orphan drug.

B) Capecitabine is available as an injection.

C) Capecitabine has not been associated with serious adverse events.

D) Capecitabine is used to treat refractory lung cancer.

E) Patients taking warfarin and capecitabine should be monitored regularly for alterations in their PT or INR.
.
 

Discussion